NASDAQ:TRUPTrupanion Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Trupanion Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $43.85 -0.50 (-1.13 %) (As of 07/7/2020 04:00 PM ET) Add Compare Share Today's Range$43.43Now: $43.85▼$44.9350-Day Range$27.69MA: $36.21▼$45.1552-Week Range$20.84Now: $43.85▼$45.88Volume180,358 shsAverage Volume386,437 shsMarket Capitalization$1.54 billionP/E RatioN/ADividend YieldN/ABeta1.56 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.Read More Beat the Market (BTM) Rank™ 1.3 Analyst's Opinion Consensus RatingTrupanion has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $38.57, Trupanion has a potential downside of 12.0% from its current price of $43.85.Amount of Analyst CoverageTrupanion has only been the subject of 3 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesTrupanion has received 498 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTrupanion has received 427 “underperform” votes. (Add your “underperform” vote.)Community SentimentTrupanion has received 53.84% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Trupanion and other stocks. Vote “Outperform” if you believe TRUP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRUP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTrupanion does not currently pay a dividend.Dividend GrowthTrupanion does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Trupanion insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,520,669.00 in company stock.Percentage Held by InsidersOnly 11.28% of the stock of Trupanion is held by insiders.Percentage Held by Institutions93.84% of the stock of Trupanion is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Trupanion are expected to grow in the coming year, from ($0.04) to ($0.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Trupanion is -877.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Trupanion is -877.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTrupanion has a P/B Ratio of 11.21. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.13 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Hospital & medical service plans Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:TRUP Previous Symbol CUSIPN/A CIK1371285 Webwww.trupanion.com Phone855-727-9079Debt Debt-to-Equity Ratio0.22 Current Ratio1.69 Quick Ratio1.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$383.94 million Price / Sales4.01 Cash Flow$0.11 per share Price / Cash Flow392.07 Book Value$3.91 per share Price / Book11.21Profitability EPS (Most Recent Fiscal Year)($0.05) Net Income$-1,810,000.00 Net Margins-0.40% Return on Equity-1.23% Return on Assets-0.66%Miscellaneous Employees586 Outstanding Shares35,100,000Market Cap$1.54 billion Next Earnings Date8/4/2020 (Estimated) OptionableOptionable NASDAQ:TRUP Rates by TradingView Receive TRUP News and Ratings via Email Sign-up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter. Trupanion (NASDAQ:TRUP) Frequently Asked Questions How has Trupanion's stock been impacted by COVID-19 (Coronavirus)? Trupanion's stock was trading at $26.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TRUP stock has increased by 68.4% and is now trading at $43.85. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Trupanion? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Trupanion. When is Trupanion's next earnings date? Trupanion is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Trupanion. How were Trupanion's earnings last quarter? Trupanion Inc (NASDAQ:TRUP) issued its earnings results on Thursday, April, 30th. The financial services provider reported ($0.03) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.04) by $0.01. The financial services provider had revenue of $111.30 million for the quarter, compared to analysts' expectations of $110.10 million. Trupanion had a negative return on equity of 1.23% and a negative net margin of 0.40%. The company's revenue for the quarter was up 28.0% on a year-over-year basis. During the same quarter last year, the business earned ($0.04) EPS. View Trupanion's earnings history. What price target have analysts set for TRUP? 8 Wall Street analysts have issued twelve-month target prices for Trupanion's shares. Their forecasts range from $20.00 to $50.00. On average, they expect Trupanion's share price to reach $38.57 in the next year. This suggests that the stock has a possible downside of 12.0%. View analysts' price targets for Trupanion. Has Trupanion been receiving favorable news coverage? News stories about TRUP stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Trupanion earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Trupanion. Are investors shorting Trupanion? Trupanion saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 8,700,000 shares, a decline of 7.1% from the June 15th total of 9,360,000 shares. Based on an average daily volume of 371,800 shares, the days-to-cover ratio is presently 23.4 days. Approximately 30.3% of the company's stock are sold short. View Trupanion's Current Options Chain. Who are some of Trupanion's key competitors? Some companies that are related to Trupanion include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Humana (HUM), Centene (CNC), Molina Healthcare (MOH) and Advanzeon Solutions (CHCR). View all competitors. What other stocks do shareholders of Trupanion own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), McEwen Mining (MUX), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Baidu (BIDU), Gilead Sciences (GILD), Starbucks (SBUX) and Splunk (SPLK). Who are Trupanion's key executives? Trupanion's management team includes the following people: Mr. Darryl Graham Andrew Rawlings, Founder, Pres, CEO & Director (Age 50)Ms. Tricia Lynn Plouf, Chief Financial Officer (Age 40)Mr. Thomas J. Houk, Chief Member Experience Officer (Age 31)Mr. Asher Benjamin Bearman, Chief Strategy Officer & Corp. Sec. (Age 41)Ms. Margaret Tooth, Chief Revenue Officer (Age 40) What is Trupanion's stock symbol? Trupanion trades on the NASDAQ under the ticker symbol "TRUP." How do I buy shares of Trupanion? Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Trupanion's stock price today? One share of TRUP stock can currently be purchased for approximately $43.85. How big of a company is Trupanion? Trupanion has a market capitalization of $1.54 billion and generates $383.94 million in revenue each year. The financial services provider earns $-1,810,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Trupanion employs 586 workers across the globe. What is Trupanion's official website? The official website for Trupanion is www.trupanion.com. How can I contact Trupanion? Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at 855-727-9079 or via email at [email protected] This page was last updated on 7/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
